Trademark: 88337582
Word
BRUKINSA ZANUBRUTINIB
Status
Registered
Status Code
700
Status Date
Tuesday, January 19, 2021
Serial Number
88337582
Registration Number
6252000
Registration Date
Tuesday, January 19, 2021
Mark Type
3000
Filing Date
Wednesday, March 13, 2019
Published for Opposition
Tuesday, December 31, 2019

Trademark Owner History
BeiGene, Ltd. - Original Registrant

Classifications
5 Pharmaceuticals comprising zanubrutinib for the treatment of cancer, autoimmune and inflammatory diseases and infectious diseases
The mark consists of an image of a mountain on the left with the words "BRUKINSA" to the right and the word "ZANUBRUTINIB" below it.
In the statement, line 1, "Corporation" should be deleted, and limited company (ltd.) should be inserted.
Color is not claimed as a feature of the mark.
"ZANUBRUTINIB"

Trademark Events
Mar 24, 2023
Teas Change Of Correspondence Received
Mar 24, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Mar 24, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Dec 8, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Dec 8, 2022
Teas Change Of Correspondence Received
Dec 8, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Dec 8, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Dec 8, 2022
Teas Change Of Owner Address Received
Mar 4, 2021
Correction Under Section 7 ¿ Processed
Mar 2, 2021
Case Assigned To Post Registration Paralegal
Feb 3, 2021
Teas Section 7 Request Received
Jan 28, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
Jan 28, 2021
Teas Change Of Correspondence Received
Jan 28, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 28, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 28, 2021
Teas Change Of Owner Address Received
Jan 19, 2021
Exparte Appeal Terminated
Jan 19, 2021
Registered-Principal Register
Dec 18, 2020
Notice Of Acceptance Of Statement Of Use E-Mailed
Dec 17, 2020
Allowed Principal Register - Sou Accepted
Dec 8, 2020
Teas/Email Correspondence Entered
Dec 8, 2020
Correspondence Received In Law Office
Dec 2, 2020
Teas Request For Reconsideration Received
Dec 2, 2020
Ex Parte Appeal-Instituted
Dec 2, 2020
Jurisdiction Restored To Examining Attorney
Dec 2, 2020
Exparte Appeal Received At Ttab
Jun 9, 2020
Notification Of Final Refusal Emailed
Jun 9, 2020
Final Refusal E-Mailed
Jun 9, 2020
Su - Final Refusal - Written
Apr 21, 2020
Teas/Email Correspondence Entered
Apr 21, 2020
Correspondence Received In Law Office
Apr 16, 2020
Teas Response To Office Action Received
Apr 16, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Apr 16, 2020
Teas Change Of Correspondence Received
Apr 16, 2020
Teas Withdrawal Of Attorney Received-Firm Retains
Apr 16, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 16, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 11, 2020
Notification Of Non-Final Action E-Mailed
Apr 11, 2020
Non-Final Action E-Mailed
Apr 11, 2020
Su - Non-Final Action - Written
Mar 23, 2020
Statement Of Use Processing Complete
Mar 4, 2020
Use Amendment Filed
Mar 23, 2020
Case Assigned To Intent To Use Paralegal
Mar 4, 2020
Teas Statement Of Use Received
Feb 25, 2020
Noa E-Mailed - Sou Required From Applicant
Dec 31, 2019
Official Gazette Publication Confirmation E-Mailed
Dec 31, 2019
Published For Opposition
Dec 11, 2019
Notification Of Notice Of Publication E-Mailed
Nov 20, 2019
Assigned To Lie
Nov 19, 2019
Approved For Pub - Principal Register
Nov 15, 2019
Examiner's Amendment Entered
Nov 15, 2019
Notification Of Examiners Amendment E-Mailed
Nov 15, 2019
Examiners Amendment E-Mailed
Nov 15, 2019
Examiners Amendment -Written
Nov 12, 2019
Teas/Email Correspondence Entered
Nov 12, 2019
Correspondence Received In Law Office
Nov 12, 2019
Teas Response To Office Action Received
May 29, 2019
Notification Of Non-Final Action E-Mailed
May 29, 2019
Non-Final Action E-Mailed
May 29, 2019
Non-Final Action Written
May 22, 2019
Assigned To Examiner
Apr 2, 2019
Notice Of Design Search Code E-Mailed
Mar 31, 2019
New Application Office Supplied Data Entered
Mar 16, 2019
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24